Literature DB >> 1849485

Identification of an additional gene belonging to the alpha 2 adrenergic receptor family in the human genome by PCR.

V Chhajlani1, N Rangel, S Uhlén, J E Wikberg.   

Abstract

We here describe the cloning of an additional gene, called alpha 2-1.8, which is similar to the previously cloned human alpha 2-adrenergic receptor located on chromosome 4. The alpha 2-1.8 gene was identified by using the polymerase chain reaction with primers specific for sequences in transmembrane regions 2 and 5 of the previously isolated human alpha 2-C4 and alpha 2-C10 adrenoceptor genes, which are localized on chromosomes 4 and 10, respectively. The new gene was identified by amplifying the 1.8 kb size fractionated region of PstI restriction cut human genomic DNA. The previously cloned alpha 2-C10 and alpha 2-C4 genes were recovered at their expected locations, 0.96 and 5.9 kb, respectively. We have identified 387 bases of the new alpha 2-1.8 gene, and its sequence is identical to the previously described alpha 2-C4 gene, but it is distinct from the alpha 2-C10 and alpha 2-C2 genes. Our results demonstrate that the alpha 2-C4 adrenergic receptor exists in more than one copy in the human genome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849485     DOI: 10.1016/0014-5793(91)80301-i

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

2.  The evolutionary divergence of neurotransmitter receptors and second-messenger pathways.

Authors:  K J Fryxell
Journal:  J Mol Evol       Date:  1995-07       Impact factor: 2.395

3.  The alpha 2-adrenoceptors of the human retinoblastoma cell line (Y79) may represent an additional example of the alpha 2C-adrenoceptor.

Authors:  M M Gleason; J P Hieble
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.